AI Model Developed Using Chest Radiographs Can Aid Detection Of Type 2 Diabetes
- byDoctor News Daily Team
- 09 July, 2025
- 0 Comments
- 0 Mins
USA: A team of researchers from the US have developed a deep learning (DL) model that can accurately identify patients with type 2 diabetes (T2D) from routine frontal chest radiographs (CXRs).
"Explainable AI (artificial intelligence) techniques revealed correlations between specific adiposity measures and high predictivity, indicating the potential of chest radiographs for enhanced T2D screening," the researchers reported.
The study, published in Nature Communications, showed that diabetes prediction in type 2 diabetes patients (including poorly controlled T2D) showed an AUC of 0.84 compared to subjects without T2D. On adding the CXR DL prediction to a logistic regression (LR) model with only non-imaging variables, the researchers observed a performance improvement in the AUC.
"Overall, there is a complementary benefit of the ensemble DL model for predicting type 2 diabetes in a large cohort," the researchers wrote.
Deep learning can harness electronic health records (EHRs) for predicting diseases and extracting radiologic findings for diagnosis. With frequently ordered ambulatory chest radiographs, Ayis Pyrros, Duly Health and Care, Department of Radiology, Downers Grove, IL, USA, and colleagues investigated type 2 diabetes detection by combining radiographic and EHR data using a DL model.
The researchers tested their model, developed from 271,065 chest radiographs and 160,244 patients, on a prospective dataset of 9,943 CXRs.
They showed that the model effectively detected type 2 diabetes with a ROC AUC of 0.84 and a 16% prevalence. The algorithm flagged 14% of the cases as suspicious for T2D. External validation at a distinct institution led to a ROC AUC of 0.77, with 5% of patients subsequently diagnosed with T2D.
Dr Pyrros and the team made some important observations from the study:
First, the DL model performed well in detecting patients with prevalent T2D, with an AUC of 0.84 in patients with BMI ≥ 25 and an AUC of 0.89 in patients with BMI < 25.
Second, the DL model increased discriminative performance and outperformed clinical LR models across multiple scenarios.
Third, the prediction of poorly controlled T2D may offer more targeted interventions to higher-risk patients, such as enhanced screening.
Fourth, the sensitivity (0.74) and specificity (0.72) of DL screening in a cohort with a BMI ≥ 25 exceeds the sensitivity and specificity of the USPSTF guidelines (0.45 and 0.69, respectively) from previously published results using the guidelines.
According to the authors, no other prospective observation study has tested the real-world performance of a DL model for T2D diagnosis based on chest radiographs.
"We developed a DL model that can accurately identify type 2 diabetes patients on routine CXRs," the researchers wrote. "Using this model in population-level health efforts could potentially allow millions of T2D patients to be identified earlier in the disease process."
Reference:
Pyrros, A., Borstelmann, S. M., Mantravadi, R., Zaiman, Z., Thomas, K., Price, B., Greenstein, E., Siddiqui, N., Willis, M., Shulhan, I., Horowitz, J. M., Nikolaidis, P., Lungren, M. P., Mario, J., Gichoya, J. W., Koyejo, S., Flanders, A. E., Khandwala, N., Gupta, A., . . . Galanter, W. (2023). Opportunistic detection of type 2 diabetes using deep learning from frontal chest radiographs. Nature Communications, 14(1), 1-12. https://doi.org/10.1038/s41467-023-39631-x
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Can creatine help with depression? New Review Find...
- 08 November, 2025
Female Patients with Culture-Negative Endocarditis...
- 08 November, 2025
Flavanols in cocoa can protect blood vessel functi...
- 08 November, 2025
Common Acne Drug May Offer Protection Against Schi...
- 08 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!